OPEN END TURBO LONG - ZEALAND PHARMA Stock

DE000MG051M7

Real-time Bid/Ask 11:38:17 2024-06-28 am EDT
5.29 ^EUR / 5.38 ^EUR	+7.78%

Current month	+171.98%
1 month	+243.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ZEALAND PHARMA A/S

Chart OPEN END TURBO LONG - ZEALAND PHARMA

Latest news about ZEALAND PHARMA A/S

Zealand Pharma major shareholder announcement: Van Herk Investments	11:10am	GL
Would you like some more inflation?	08:56am
Zealand Pharma completes registration of capital increase	02:37am	GL
Zealand Pharma Upsizes Directed Share Offering to $1 Billion Amid Strong Demand	Jun. 26	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-28	5.14	+3.84%
24-06-27	4.95	-1.39%
24-06-26	5.02	-2.90%
24-06-25	5.17	+22.51%
24-06-24	4.22	+19.89%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 08:31 am EDT

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	ZEALAND PHARMA A/S
Issuer	Morgan Stanley
WKN	MG051M
ISIN	DE000MG051M7
Date issued	2024-03-13
Strike	513.2 kr
Maturity	Unlimited
Parity	10 : 1
Emission price	2.51 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	5.34 €
Lowest since issue	1.02 €
Spread	0.09 €
Spread %	1.67%

Company Profile

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.

Sector

More about the company

Ratings for Zealand Pharma A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Zealand Pharma A/S

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

869.5 DKK

Average target price

918 DKK

Spread / Average Target

+5.58%

Consensus